XML 48 R38.htm IDEA: XBRL DOCUMENT v3.25.3
Shareholders' Equity and Debt (Details) - USD ($)
3 Months Ended 9 Months Ended
Feb. 05, 2025
Sep. 05, 2023
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Feb. 14, 2025
Dec. 31, 2024
May 06, 2024
Mar. 20, 2024
Dec. 31, 2021
Aug. 31, 2020
Jan. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Repurchased shares     $ 10,439 $ 7,170 $ 243,705 $ 102,194 $ 126,689 $ 246,599                  
Shares purchased                 11,992                
Common shares left to repurchase     2,200,000           $ 2,200,000                
Expiration period   3 years                              
Borrowings outstanding     5,240,733           5,240,733     $ 10,176,170          
gross proceed of ATM share issuance $ 5,500,000                                
WinHealth                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Initial investment in joint ventures                               $ 200,000  
WinHealth | Convertible Debt                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Convertible note                               $ 200,000  
Revolving Credit Facility                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Borrowings outstanding     $ 5,200,000           $ 5,200,000     $ 15,300,000          
Revolving Credit Facility | Pinnacle Bank                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Line of credit, maximum borrowing capacity   $ 25,000,000                     $ 20,000,000   $ 20,000,000    
Revolving Credit Facility | Pinnacle Bank | Line of Credit                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Variable rate   2.75%                              
Interest rate spread     7.00%           7.00%                
Restricted Stock                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Restricted stock granted in period, shares                 35,110 50,500              
Share-based compensation credit                 $ 200,000 $ 200,000              
Restricted Stock | Director                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Restricted stock awards, vesting period                 1 year                
Incentive Stock Options                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Restricted stock granted in period, shares                 182,150 190,450              
Forfeitured                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Share-based compensation credit                 $ 7,001 $ 22,058              
Common Stock                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Authorized amount                                 $ 10,000,000
Repurchase of shares (in shares)     3,310 1,800 53,837 72,447 76,771 125,870 58,947 275,088              
Repurchased shares     $ 10,439 $ 7,170 $ 243,705 $ 102,194 $ 126,689 $ 246,599 $ 300,000 $ 500,000              
Share issuances (in shares)         1,000,000                        
Common Stock | ATM                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Shelf registration, sale of corporate securities (up to)                     $ 10,000,000     $ 5,800,000      
Deferred offering costs $ 600,000                                
Share issuances (in shares) 1,000,000